Regulatory & Compliance

With the FDA's recent approval of an oral weight loss medication, the ground is shifting in one of the most lucrative and rapidly evolving sectors of the pharmaceutical industry. This new pill-based treatment promises greater convenience for millions, setting the stage for an intensified rivalry

The Dawn of a New ErWashington's Push for AI-Powered Healthcare The U.S. Department of Health and Human Services (HHS) has initiated a pivotal effort to accelerate the integration of artificial intelligence into the heart of American medicine, signaling a potential paradigm shift in clinical care.

Navigating the labyrinth of American healthcare costs has long been a source of profound confusion and anxiety for consumers, often leaving them in the dark about the true price of care until a bill arrives. In a direct response to this persistent challenge, the Trump administration has proposed a

Today, we're speaking with James Maitland, an expert in healthcare innovation and the intricate dynamics between the pharmaceutical industry, government policy, and financial markets. We'll be exploring the recent wave of drug pricing deals between major pharmaceutical companies and the White

The long-promised transformation of American healthcare from a system that pays for the quantity of services to one that rewards the quality of patient outcomes is reaching a pivotal and defining moment. This ongoing, critical shift away from the traditional fee-for-service model is more than a

The U.S. Food and Drug Administration (FDA) finds itself navigating a complex and fractured landscape as it endeavors to craft a regulatory framework for the real-world performance of medical devices driven by artificial intelligence (AI) and machine learning (ML). Following a call for public